Moving prostate cancer polygenic risk scores from research towards clinical practice

JT Kearns, BT Helfand, J Xu - European Urology Focus, 2022 - Elsevier
Recent advances in our understanding of genetic factors that contribute to prostate cancer
(PCa) susceptibility have the potential to improve disease screening, diagnosis, and …
被引用次数：3 相关文章

Moving Prostate Cancer Polygenic Risk Scores from Research Towards Clinical Practice

JT Kearns, BT Helfand, J Xu - European urology focus, 2022 - pubmed.ncbi.nlm.nih.gov
Recent advances in our understanding of genetic factors that contribute to prostate cancer
(PCa) susceptibility have the potential to improve disease screening, diagnosis, and …

Moving Prostate Cancer Polygenic Risk Scores from Research Towards Clinical Practice.

JT Kearns, BT Helfand, J Xu - European Urology Focus, 2022 - europepmc.org
Recent advances in our understanding of genetic factors that contribute to prostate cancer
(PCa) susceptibility have the potential to improve disease screening, diagnosis, and …

Moving Prostate Cancer Polygenic Risk Scores from Research Towards Clinical Practice

JT Kearns, BT Helfand, J Xu - European Urology …, 2022 - eu-focus.europeanurology.com
Recent advances in our understanding of genetic factors that contribute to prostate cancer
(PCa) susceptibility have the potential to improve disease screening, diagnosis, and …